ClinicalTrials.gg
Sign In

Chongqing Genrix Biopharmaceutical Co., Ltd clinical trials

Part of Chongqing Zhirui Investment Co., Ltd., which holds 54.54% as of 2025-12-31. Source

The registry lists 29 studies whose lead sponsor is Chongqing Genrix Biopharmaceutical Co., Ltd or one of 1 company grouped under it. 18 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 10, 2026.

Our grouping of 2 registry names, not the registry’s. See them and correct one ↓

Get an email when these change. Save the Chongqing Genrix Biopharmaceutical Co., Ltd studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Pipeline: 5 programmes

Each counted once: 5 with a study Chongqing Genrix Biopharmaceutical Co., Ltd leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 2 phase-3 programmes — sign in to see them, free: with every programme, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Chongqing Genrix Biopharmaceutical Co., Ltd’s own registered studies; Chongqing Genrix Biopharmaceutical Co., Ltd’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programmes are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Chongqing Genrix Biopharmaceutical Co., Ltd’s studies test, most open studies first — 5 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

5 of Chongqing Genrix Biopharmaceutical Co., Ltd’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. 2M
  8. 1J
  9. 2J
  10. A
  11. S
  12. O
  13. N

All 5

Add all 5 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 15, 2026.

Newly registered1

All 29 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1862%Not yet recruiting 10 · Recruiting 8
  • Under way, not recruiting414%
  • Completed724%

Phase

  • Phase 214
  • Phase 112
  • Phase 38

Where

Over the years

  1. 20
  2. 21
  3. 22
  4. 23
  5. 24
  6. 725
  7. 526

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Chongqing Genrix Biopharmaceutical Co., Ltd.

  • Genrix (Shanghai) Biopharmaceutical Co., Ltd.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    28 studies →
  • Chongqing Genrix Biopharmaceutical Co., Ltd
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study

Studies

Recruiting first, then most recently updated. Showing 29 of 29.